Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Aesica Expands In Queenborough

by Rick Mullin
January 25, 2016 | A version of this story appeared in Volume 94, Issue 4

[+]Enlarge
Credit: Aesica
Technicians at Aesica’s expanded Queenborough site.
A picture of technicians at Aesica’s expanded Queenborough site.
Credit: Aesica
Technicians at Aesica’s expanded Queenborough site.

Aesica, a British pharmaceutical chemicals firm, has relocated its development and clinical-scale manufacturing services business from Nottingham to Queenborough, England. The move allows the firm to provide a full range of active pharmaceutical ingredient manufacturing and formulation services at the Queenborough site, which it acquired from Abbott Laboratories in 2007. In particular, Aesica says the site can manufacture solid and liquid dosage forms for Phase I to III clinical trials.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.